EMUNE
LIVE

Serial Number

79271265

Owner

EMUNE AB

Attorney

Sarah J. Schneider

Filing Date

Sep 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

EMUNE Trademark

Serial Number: 79271265 • Registration: 7317975

EMUNE is a trademark filed by EMUNE AB on September 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EMUNE AB

KI Innovations,

Entity Type: 03

Trademark Details

Filing Date

September 18, 2019

Registration Date

March 5, 2024

Published for Opposition

December 19, 2023

Goods & Services

apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity, namely, electric sensors, arrays and nanoelectronics being electrodes, and microchips and biochips for research or scientific purposes; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, namely, CDs, DVDs, and downloadable data, audio and video files, all featuring information in the field of medical diagnoses, medical treatment and monitoring information and data, and bioelectronic and biomedical diagnosing, treating and monitoring information and data; downloadable computer software for use in processing electromedical and biomedical equipment and data; blank digital or analogue recording and storage media; computers and computer peripheral devices; downloadable computer software for use in operating medical decision support systems; downloadable computer programmes for data processing; downloadable application software for managing cloud computing services

Pharmaceuticals, medical and veterinary preparations for diagnosing and treating inflammatory and autoimmune diseases, disorders and conditions, motor disabilities and neurological conditions; sanitary preparations for medical purposes; disinfectants; adhesive tapes for medical purposes

Medical services; medical treatment services; medical diagnostic services; medical services in the nature of monitoring the state of health of patients; providing medical data to patients and healthcare professionals from a database or from the internet; information services relating to health care

Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments for diagnosing and treating inflammatory and autoimmune diseases, disorders and conditions, motor disabilities and neurological conditions; electronic medical instruments for the treatment, management and therapy of chronic medical conditions, namely, devices for treating inflammatory and autoimmune diseases, disorders and conditions, motor disabilities and neurological conditions; electronic nerve stimulators for medical use

Hosting of computerized data, files, applications and information, namely, hosting of digital content on the internet; electronic data storage; data conversion of electronic information; web site hosting services; software as a service (SaaS) services featuring software for analyzing information and data in diagnosis and treatment of inflammatory and autoimmune diseases, disorders and conditions, motor disabilities and neurological conditions; rental of software; provision of technical support in the operation of computing networks in the nature of troubleshooting of computer software problems

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 5, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 5, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Dec 18, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 29, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 29, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 14, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 14, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 14, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 14, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 24, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 25, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 25, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 25, 2023 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 18, 2023 RCCK
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 20, 2023 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 27, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 8, 2021 RCSC
NEW REPRESENTATIVE AT IB RECEIVED
May 1, 2021 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 24, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 7, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 7, 2021 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 10, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 10, 2020 GNSL
SUSPENSION LETTER WRITTEN
Aug 10, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2020 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 30, 2020 ADCH
REFUSAL PROCESSED BY IB
Feb 8, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 21, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 21, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 24, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 23, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 19, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 13, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 7, 2019 REPR